Mankind Pharma Limited (NSE: MANKIND)

Mankind Pharma Statistics

Total Valuation

Mankind Pharma has a market cap or net worth of INR 1.08 trillion. The enterprise value is 1.05 trillion.

Market Cap	1.08T
Enterprise Value	1.05T

Important Dates

The next estimated earnings date is Thursday, October 31, 2024.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	n/a

Share Statistics

Mankind Pharma has 400.64 million shares outstanding. The number of shares has increased by 0.14% in one year.

Shares Outstanding	400.64M
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	59.46%
Owned by Institutions (%)	13.55%
Float	93.99M

Valuation Ratios

The trailing PE ratio is 54.88 and the forward PE ratio is 46.33. Mankind Pharma's PEG ratio is 2.76.

PE Ratio	54.88
Forward PE	46.33
PS Ratio	10.10
PB Ratio	11.48
P/FCF Ratio	n/a
PEG Ratio	2.76

Enterprise Valuation

EV / Earnings	53.28
EV / Sales	9.82
EV / EBITDA	40.54
EV / EBIT	48.13
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	0.08
Debt / FCF	n/a
Interest Coverage	65.07

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	15.35%
Revenue Per Employee	5.45M
Profits Per Employee	1.00M
Employee Count	19,540
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +49.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+49.67%
50-Day Moving Average	2,385.59
200-Day Moving Average	2,217.77
Relative Strength Index (RSI)	62.02
Average Volume (20 Days)	592,296

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mankind Pharma had revenue of INR 106.50 billion and earned 19.63 billion in profits. Earnings per share was 48.91.

Revenue	106.50B
Gross Profit	73.36B
Operating Income	21.58B
Pretax Income	24.43B
Net Income	19.63B
EBITDA	25.60B
EBIT	21.58B
Earnings Per Share (EPS)	48.91

Balance Sheet

The company has 33.86 billion in cash and 2.07 billion in debt, giving a net cash position of 31.79 billion or 79.36 per share.

Cash & Cash Equivalents	33.86B
Total Debt	2.07B
Net Cash	31.79B
Net Cash Per Share	79.36
Equity (Book Value)	95.76B
Book Value Per Share	233.73
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 68.89%, with operating and profit margins of 20.27% and 18.43%.

Gross Margin	68.89%
Operating Margin	20.27%
Pretax Margin	22.94%
Profit Margin	18.43%
EBITDA Margin	24.04%
EBIT Margin	20.27%
FCF Margin	n/a

Dividends & Yields

Mankind Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.14%
Shareholder Yield	-0.14%
Earnings Yield	1.82%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a